Researchers sought to develop and validate artificial neural networks for overall survival and progression-free survival in older adults with HNSCC following definitive chemoradiation.

Cigarette smoking decreased from 42 percent in 1965 to 11.5 percent in 2023; few eligible adults are up to date with lung cancer screening.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

Researchers investigated non-melanoma skin cancer prevalence among sexual orientation identities by race/ethnicity and gender.

Researchers assessed whether combination mosunetuzumab and polatuzumab vedotin would reduce the risk of disease progression or death in patients with LBCL.